News

Energy expended for hospital and clinic electricity, climate control and ventilation is by far the biggest source of greenhouse gas emissions in radiotherapy, a treatment used in more than half of cancer cases, a new study found. The Lancet Oncology study, led by UC San Francisco researchers, sought

UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group. Despite a growing incidence of cancers that in some cases exceed those of other groups, there

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, which was held

A type of gene therapy called CAR-T that has extended survival for thousands of patients with leukemia and other blood cancers is being adapted at UC San Francisco to treat people with glioblastoma, the most common and deadly adult brain tumor. This new more powerful version of CAR-T employs a novel

Advances in targeted therapy, cancer genomics and eliminating treatment disparities among the topics that will be presented by leading cancer researchers from UC San Francisco at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 5-10, in San

The ideal therapy for a disease works exclusively at the site of the disease. But when it comes to the brain, which is wrapped in a protective barrier and contains thousands of different cell types, this ideal is very hard to achieve. Now, scientists at UC San Francisco have been awarded more than